Moreover, the treatment with a small heat shock protein alpha B-crystallin (HspB5) resulted in a progressive decline in MS lesion activity, i.e., in a 76% reduction in the number and total volumes of active MRI lesions at 9 months [42]. This evidence concerns the gene CRYAB and myeloid sarcoma.